Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | IDE | P14735 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TOP1 | P11387 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3189808 | 1.00 | APP (0.35) | APPMEN1USP2POLBMAPT | |
| SCHEMBL9628464 | 0.81 | MEN1 (0.34) | APPMEN1USP2POLBMAPT | |
| SCHEMBL9488321 | 0.81 | MEN1 (0.34) | APPMEN1USP2POLBMAPT | |
| SCHEMBL13773165 | 0.77 | MEN1 (0.41) | APPMEN1POLBKMT2A | |
| Acrylic Acid SCHEMBL11402394 | 0.74 | LMNA (0.33) | MEN1USP2POLBMAPTIDE | |
| SCHEMBL10922299 | 0.73 | APP (0.42) | APPMEN1MAPTKMT2A | |
| SCHEMBL9892485 | 0.73 | APP (0.42) | APPMEN1MAPTKMT2A | |
| SCHEMBL3203789 | 0.73 | CYP2C9 (0.52) | MEN1USP2POLBMAPTKMT2A | |
| SCHEMBL11207088 | 0.72 | TDP1 (0.34) | — | |
| Acrylamide SCHEMBL9488521 | 0.71 | ALDH1A1 (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9068080-B2 | Merocyanine derivatives | BASF SE (DE) | 2015-06-30 | — | — | US | disclosed |
| US-20100035839-A1 | MEROCYANINE DERIVATIVES | CIBA CORPORATION (US) | 2010-02-11 | — | — | US | disclosed |
| EP-2125961-A1 | MEROCYANINE DERIVATIVES | Ciba Holding Inc. (CH) | 2009-12-02 | — | — | EP | disclosed |
| WO-2008080645-A1 | MEROCYANINE DERIVATIVES | CIBA HOLDING INC. (CH) | 2008-07-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100035839-A1 | MEROCYANINE DERIVATIVES | C1R, MC5R, C2CD5 | APP 3148/4885MEN1 603/4885USP2 1999/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.